Securities Code: 002399 Securities Abbreviation: Hyprey Shenzhen Hyprey Pharmaceutical Group Co., Ltd. 2025 Annual Goodwill Impairment Test Report
I. Whether to conduct an impairment test ☑ Yes
II. Whether an independent financial report was obtained in the impairment test ☑ Yes
| Asset Group Name | Appraisal Institution | Appraiser | Appraisal Report Number | Valuation Type | Appraisal Result |
|---|---|---|---|---|---|
| Raw Materials Asset Group | KPMG LLP | Recoverable Amount | As of the valuation date (December 31, 2025), the carrying amount of the Raw Materials asset group, excluding goodwill, was RMB 1.825 billion. The carrying amount of goodwill was RMB 1.491 billion, totaling RMB 3.316 billion for the asset group including goodwill. The recoverable amount was determined as the higher of the present value of future cash flows and the fair value less costs to sell. The recoverable amount for this asset group was assessed at RMB 4.174 billion. Since the recoverable amount exceeds the carrying amount of the asset group including goodwill, no impairment of goodwill is recognized. | ||
| CDMO Asset Group | KPMG LLP | Recoverable Amount | As of the valuation date (December 31, 2025), the carrying amount of the CDMO asset group, excluding goodwill, was RMB 0.764 billion. The carrying amount of goodwill was RMB 0.814 billion, totaling RMB 1.578 billion for the asset group including goodwill. The recoverable amount was determined as the higher of the present value of future cash flows and the fair value less costs to sell. The recoverable amount for this asset group was assessed at RMB 2.007 billion. Since the recoverable amount exceeds the carrying amount of the asset group including goodwill, no impairment of goodwill is recognized. |
III. Indications of impairment
| Asset Group Name | Indications of Impairment | Remarks | Whether Impairment Loss Was Recognized | Remarks | Impairment Basis |
|---|---|---|---|---|---|
| Raw Materials Asset Group | No indications of impairment | No | Not applicable for non-impairment | ||
| CDMO Asset Group | No indications of impairment | No | Not applicable for non-impairment |
IV. Goodwill Allocation
Unit: RMB